Kolon Corporation (KRX:002020)
South Korea · Delayed Price · Currency is KRW 61,200
+1,900 (3.20%)
Apr 15, 2026, 3:30 PM KST
Kolon Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,821,815 | 5,892,949 | 5,851,987 | 5,594,862 | 5,344,695 |
Other Revenue | 64,318 | 27,062 | 26,446 | 65,060 | 65,720 |
| 5,886,133 | 5,920,011 | 5,878,432 | 5,659,922 | 5,410,415 | |
Revenue Growth (YoY) | -0.57% | 0.71% | 3.86% | 4.61% | 10.64% |
Cost of Revenue | 5,367,196 | 5,517,002 | 5,401,333 | 4,976,197 | 4,746,477 |
Gross Profit | 518,937 | 403,008 | 477,099 | 683,725 | 663,938 |
Selling, General & Admin | 337,191 | 311,013 | 312,798 | 302,817 | 275,298 |
Research & Development | 10,250 | 6,901 | 4,236 | 2,536 | 1,576 |
Amortization of Goodwill & Intangibles | 2,259 | 4,055 | 4,086 | 4,554 | 4,545 |
Other Operating Expenses | 9,265 | 10,512 | 11,083 | 9,722 | 8,848 |
Operating Expenses | 568,895 | 493,950 | 356,077 | 367,518 | 337,614 |
Operating Income | -49,958 | -90,941 | 121,022 | 316,207 | 326,324 |
Interest Expense | -154,202 | -182,498 | -118,987 | -68,980 | -48,408 |
Interest & Investment Income | 30,310 | 40,458 | 28,216 | 26,297 | 10,161 |
Earnings From Equity Investments | -10,173 | 217,122 | -21,667 | 18,574 | -46,447 |
Currency Exchange Gain (Loss) | -9,364 | -21,834 | -2,324 | -9,318 | -8,911 |
Other Non Operating Income (Expenses) | -156,459 | 7,758 | 4,189 | 4,663 | -8,778 |
EBT Excluding Unusual Items | -349,847 | -29,935 | 10,449 | 287,442 | 223,940 |
Impairment of Goodwill | -2,654 | -14,942 | -4,759 | - | - |
Gain (Loss) on Sale of Investments | 25,971 | 12,362 | 11,077 | 2,562 | 25,761 |
Gain (Loss) on Sale of Assets | 4,422 | 285,924 | 638.05 | 3,053 | 1,967 |
Asset Writedown | -49,406 | -20,396 | 4,840 | -6,071 | -9,551 |
Other Unusual Items | - | - | 155.1 | - | - |
Pretax Income | -371,513 | 233,013 | 22,401 | 286,986 | 242,116 |
Income Tax Expense | -75,220 | 57,652 | 7,443 | 92,151 | 85,322 |
Earnings From Continuing Operations | -296,293 | 175,360 | 14,958 | 194,835 | 156,795 |
Earnings From Discontinued Operations | -312.83 | -3,364 | 429.58 | - | - |
Net Income to Company | -296,606 | 171,996 | 15,387 | 194,835 | 156,795 |
Minority Interest in Earnings | 138,134 | 12,731 | -6,821 | -34,956 | -28,417 |
Net Income | -158,472 | 184,727 | 8,566 | 159,880 | 128,377 |
Net Income to Common | -158,472 | 184,727 | 8,566 | 159,880 | 128,377 |
Net Income Growth | - | 2056.44% | -94.64% | 24.54% | -6.44% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 |
Shares Change (YoY) | 0.57% | -0.42% | -0.82% | -0.27% | 1.16% |
EPS (Basic) | -11476.00 | 13477.00 | 625.15 | 11667.67 | 9368.68 |
EPS (Diluted) | -11476.00 | 13454.00 | 625.15 | 11501.15 | 9210.27 |
EPS Growth | - | 2052.13% | -94.56% | 24.87% | -7.51% |
Free Cash Flow | -76,924 | -291,840 | -341,296 | 185,620 | 184,199 |
Free Cash Flow Per Share | -5570.56 | -21255.21 | -24753.87 | 13352.76 | 13215.09 |
Dividend Per Share | - | - | 550.000 | 550.000 | 550.000 |
Gross Margin | 8.82% | 6.81% | 8.12% | 12.08% | 12.27% |
Operating Margin | -0.85% | -1.54% | 2.06% | 5.59% | 6.03% |
Profit Margin | -2.69% | 3.12% | 0.15% | 2.83% | 2.37% |
Free Cash Flow Margin | -1.31% | -4.93% | -5.81% | 3.28% | 3.40% |
EBITDA | 44,140 | 3,579 | 204,559 | 389,616 | 407,786 |
EBITDA Margin | 0.75% | 0.06% | 3.48% | 6.88% | 7.54% |
D&A For EBITDA | 94,098 | 94,521 | 83,537 | 73,409 | 81,463 |
EBIT | -49,958 | -90,941 | 121,022 | 316,207 | 326,324 |
EBIT Margin | -0.85% | -1.54% | 2.06% | 5.59% | 6.03% |
Effective Tax Rate | - | 24.74% | 33.23% | 32.11% | 35.24% |
Advertising Expenses | 25,117 | 23,385 | 20,578 | 16,585 | 12,445 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.